DRAK2-IN-1, compound 16, is a potent, selective and ATP-competitive DRAK2 inhibitor with IC50and Kivalues of 3 nM and 0.26 nM, respectively. DRAK2-IN-1 also has inbitory effect on DRAK1 (IC50=51 nM).

Product information

CAS Number: 871837-60-4

Molecular Weight: 376.41

Formula: C21H20N4O3

Chemical Name: N-[(Z, 3Z)-3-(hydroxyimino)-2'-oxo-1', 2'-dihydro-1H, 3H-[2, 3'-biindolyliden]-5'-yl]pentanamide

Smiles: CCCCC(=O)NC1=CC2/C(=C3/NC4=CC=CC=C4/C/3=N/O)/C(=O)NC=2C=C1

InChiKey: QSDUMEKQISKWQM-PMBVCKSESA-N

InChi: InChI=1S/C21H20N4O3/c1-2-3-8-17(26)22-12-9-10-16-14(11-12)18(21(27)24-16)20-19(25-28)13-6-4-5-7-15(13)23-20/h4-7,9-11,23,28H,2-3,8H2,1H3,(H,22,26)(H,24,27)/b20-18-,25-19-

Technical Data

Appearance: Solid Power

Purity: ≥98% (or refer to the Certificate of Analysis)

Solubility: Soluble in DMSO

Shipping Condition: Shipped under ambient temperature as non-hazardous chemical or refer to Certificate of Analysis

Storage Condition: Dry, dark and -20 ^oC for 1 year or refer to the Certificate of Analysis.

Shelf Life: ≥12 months if stored properly.

Stock Solution Storage: 0 - 4 ^oC for 1 month or refer to the Certificate of Analysis.

Drug Formulation: To be determined

HS Tariff Code: 382200

References:

1. Jung ME, et al.Discovery of indirubin derivatives as new class of DRAK2 inhibitors from high throughput screening.Bioorg Med Chem Lett. 2016 Jun 1;26(11):2719-23

Products are for research use only. Not for human use.